EUVIMEDEUVIMED entdecken
Crossref

Migrasome-related prognostic signature TSPAN4 correlates with immune infiltrates and metabolic disturbances in hepatocellular carcinoma

Xiaoli Zhang, Jianzhou Li, Yichen Yao, Mimi Zhou, Yingli He, Yalei Zhao

Journal of Gastroenterology · 2025-05 · 60 (5) · 593-606

DOI: 10.1007/s00535-025-02212-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 12.01.2025. Verfasst von Xiaoli Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, West Yanta Road 277, Xi'an, 710061, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tetraspanins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: the Fundamental Research Funds for the Central Universities, the Institutional Foundation of the First Affiliated hospital of Xi'an Jiaotong University, Natural Science Basic Research Program of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We aim to comprehensively analyze and validate the prognostic efficacy of tetraspanin 4 (TSPAN4) and several other migrasome-related markers in hepatocellular carcinoma (HCC). METHODS: The expression, diagnostic, and prognostic efficacy of five migrasome-related genes in HCC were analyzed using several databases. Five pairs of adjacent non-tumor tissues and HCC tissues were used to validate the expression. The prognostic efficacy of TSPAN4 was validated in a HCC cohort. TSPAN4 was knocked down in Huh-7 cells, EdU, and CCK-8, and wound healing assays were conducted to analyze its effects on cell proliferation and migration. In addition, transcriptomic sequencing was used to identify differentially expressed genes. RESULTS: Compared with those in normal tissues, four genes (TSPAN4, PIGK, NDST1, and CPQ) were elevated in liver hepatocellular carcinoma (LIHC), but not TSPAN7. Of these, only elevated TSPAN4 predicted unfavorable prognosis of HCC patients. The expression and prognostic efficacy of TSPAN4 were further confirmed in a HCC cohort (97 patients); and patients in the TSPAN4high group showed unfavorable overall survival (log-rank P = 0.0055). Functional analysis showed that TSPAN4 knockdown significantly suppressed cell migration, but not cell proliferation. Moreover, TSPAN4 knockdown induced disturbances of the metabolic pathways, mainly pentose and glucuronate interconversions. CONCLUSIONS: TPSAN4 is a promising prognostic and therapeutic target for HCC treatment and may be involved in the metabolic pathways that affect disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTetraspaninsHumansPrognosisCell ProliferationMaleFemaleCell MovementBiomarkers, TumorMiddle AgedCell Line, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Hepatocellular carcinomaMetabolicMigrasomePrognosisTetraspanin 4

Substanzen

TetraspaninsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, West Yanta Road 277, Xi'an, 710061, China.
  • National Regional Infectious Diseases Center Co-Constructed By National Health Commission of PRC and People's Government of Shaanxi Province, Xi'an, 710061, Shaanxi, China.
  • Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China.
  • Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, West Yanta Road 277, Xi'an, 710061, China. heyingli2000@xjtu.edu.cn.
  • National Regional Infectious Diseases Center Co-Constructed By National Health Commission of PRC and People's Government of Shaanxi Province, Xi'an, 710061, Shaanxi, China. heyingli2000@xjtu.edu.cn.
  • Department of Infectious Diseases, the First Affiliated Hospital of Xi'an Jiaotong University, West Yanta Road 277, Xi'an, 710061, China. ylzhao@xjtu.edu.cn.

Förderung

  • the Fundamental Research Funds for the Central Universities
  • the Institutional Foundation of the First Affiliated hospital of Xi'an Jiaotong University
  • Natural Science Basic Research Program of Shaanxi Province
  • the Institutional Foundation of the First Affiliated hospital of Xi’an Jiaotong University

Zitieren

APA

Zhang, X., Li, J., Yao, Y., Zhou, M., He, Y., & Zhao, Y. (2025). Migrasome-related prognostic signature TSPAN4 correlates with immune infiltrates and metabolic disturbances in hepatocellular carcinoma. Journal of Gastroenterology, 60(5), 593-606. https://doi.org/10.1007/s00535-025-02212-4

Vancouver

Zhang X, Li J, Yao Y, Zhou M, He Y, Zhao Y. Migrasome-related prognostic signature TSPAN4 correlates with immune infiltrates and metabolic disturbances in hepatocellular carcinoma. Journal of Gastroenterology. 2025;60(5):593-606. doi:10.1007/s00535-025-02212-4

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiaoli and Li, Jianzhou and Yao, Yichen and Zhou, Mimi and He, Yingli and Zhao, Yalei},
  title = {Migrasome-related prognostic signature TSPAN4 correlates with immune infiltrates and metabolic disturbances in hepatocellular carcinoma},
  journal = {Journal of Gastroenterology},
  year = {2025},
  volume = {60},
  number = {5},
  pages = {593--606},
  doi = {10.1007/s00535-025-02212-4}
}
Kostenlos starten →